Evaluating the Clinical Utility of Modified Ventilator-Associated Event Criteria in Predicting IC… (NCT07212881) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evaluating the Clinical Utility of Modified Ventilator-Associated Event Criteria in Predicting ICU Mortality and Ventilator Duration: Can Less Restrictive Definitions Improve Prediction?
Egypt200 participantsStarted 2025-03-01
Plain-language summary
Study design: A prospective observational study
* Study setting: The study will be carried out in the department of critical care medicine, Benha university hospitals.
* Study time: The study time is set to a period of one year from March 2025 to March 2026.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients (age ≥ 18 years) undergoing mechanical ventilation for ≥ 48 hours.
* Patients admitted to ICU for
* medical
* trauma
* surgical conditions.
Exclusion Criteria:
* Age below 18 years.
* extracorporeal life support (ECLS).
* Incomplete or inconsistent daily monitoring data.
* Patients with confirmed or suspected respiratory viral infections (e.g., influenza, COVID-19).
* undergoing palliative care or with a do-not-intubate (DNI) status.
* Pregnant patients due to altered physiological responses.
* Patients ventilated for less than 48 hours.
* chronic ventilator dependency prior to ICU admission.
* incomplete medical documentation impacting data collection or outcome analysis.
* severe immunosuppression, such as recent bone marrow or organ transplant recipients, and those on high-dose corticosteroids.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.